377 related articles for article (PubMed ID: 30285841)
1. Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse.
Lanzillotta M; Della-Torre E; Milani R; Bozzolo E; Bozzalla-Cassione E; Rovati L; Arcidiacono PG; Partelli S; Falconi M; Ciceri F; Dagna L
Arthritis Res Ther; 2018 Oct; 20(1):222. PubMed ID: 30285841
[TBL] [Abstract][Full Text] [Related]
2. Effects of glucocorticoids on B-cell subpopulations in patients with IgG4-related disease.
Lanzillotta M; Della-Torre E; Milani R; Bozzolo E; Bozzalla-Cassione E; Rovati L; Arcidiacono PG; Partelli S; Falconi M; Ciceri F; Dagna L
Clin Exp Rheumatol; 2019; 37 Suppl 118(3):159-166. PubMed ID: 30652677
[TBL] [Abstract][Full Text] [Related]
3. Circulating plasmablasts/plasma cells: a potential biomarker for IgG4-related disease.
Lin W; Zhang P; Chen H; Chen Y; Yang H; Zheng W; Zhang X; Zhang F; Zhang W; Lipsky PE
Arthritis Res Ther; 2017 Feb; 19(1):25. PubMed ID: 28183334
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of iguratimod plus corticosteroid as bridge therapy in treating mild IgG4-related diseases: A prospective clinical trial.
Zhang P; Gong Y; Liu Z; Liu Y; Lin W; Li J; Wang M; Liu X; Fei Y; Chen H; Peng L; Li J; Zhou J; Shi Q; Zhang X; Shen M; Zeng X; Zhang F; Li Y; Zhao Y; Zhang W
Int J Rheum Dis; 2019 Aug; 22(8):1479-1488. PubMed ID: 31245907
[TBL] [Abstract][Full Text] [Related]
5. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease.
Mattoo H; Mahajan VS; Della-Torre E; Sekigami Y; Carruthers M; Wallace ZS; Deshpande V; Stone JH; Pillai S
J Allergy Clin Immunol; 2014 Sep; 134(3):679-87. PubMed ID: 24815737
[TBL] [Abstract][Full Text] [Related]
6. Clinical value of plasmablasts in predicting disease relapse in patients with IgG4-related disease.
Wang Y; Zhao Z; Gao D; Wang H; Liao S; Luo G; Ji X; Li Y; Wang X; Zhao Y; Li K; Zhang J; Jin J; Zhang Y; Zhu J; Zhang J; Huang F
Clin Rheumatol; 2023 Jan; 42(1):135-143. PubMed ID: 36074221
[TBL] [Abstract][Full Text] [Related]
7. A CD8α- Subset of CD4+SLAMF7+ Cytotoxic T Cells Is Expanded in Patients With IgG4-Related Disease and Decreases Following Glucocorticoid Treatment.
Della-Torre E; Bozzalla-Cassione E; Sciorati C; Ruggiero E; Lanzillotta M; Bonfiglio S; Mattoo H; Perugino CA; Bozzolo E; Rovati L; Arcidiacono PG; Balzano G; Lazarevic D; Bonini C; Falconi M; Stone JH; Dagna L; Pillai S; Manfredi AA
Arthritis Rheumatol; 2018 Jul; 70(7):1133-1143. PubMed ID: 29499100
[TBL] [Abstract][Full Text] [Related]
8. Relapse predictors and serologically unstable condition of IgG4-related disease: a large Chinese cohort.
Liu Y; Zeng Q; Zhu L; Gao J; Wang Z; Wang Z; Yang F; Wang K; Chen D; Xia C; Zhang S; Wang Y; Shen D; Yu G; Li ZG
Rheumatology (Oxford); 2020 Aug; 59(8):2115-2123. PubMed ID: 32097488
[TBL] [Abstract][Full Text] [Related]
9. Rituximab Maintenance Therapy Reduces Rate of Relapse of Pancreaticobiliary Immunoglobulin G4-related Disease.
Majumder S; Mohapatra S; Lennon RJ; Piovezani Ramos G; Postier N; Gleeson FC; Levy MJ; Pearson RK; Petersen BT; Vege SS; Chari ST; Topazian MD; Witzig TE
Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1947-1953. PubMed ID: 29526692
[TBL] [Abstract][Full Text] [Related]
10. Clinical manifestations, clinical course, and outcomes of immunoglobulin G4-related disease.
Phaopraphat K; Ngamjanyaporn P; Narongroeknawin P; Kasitanon N; Katchamart W
Int J Rheum Dis; 2020 Nov; 23(11):1468-1473. PubMed ID: 32808722
[TBL] [Abstract][Full Text] [Related]
11. Increased Circulating Th1 and Tfh1 Cell Numbers Are Associated with Disease Activity in Glucocorticoid-Treated Patients with IgG4-Related Disease.
Xia C; Liu C; Liu Y; Long Y; Xu L; Liu C
J Immunol Res; 2020; 2020():3757015. PubMed ID: 33313326
[TBL] [Abstract][Full Text] [Related]
12. Failure of remission induction by glucocorticoids alone or in combination with immunosuppressive agents in IgG4-related disease: a prospective study of 215 patients.
Wang L; Zhang P; Wang M; Feng R; Lai Y; Peng L; Fei Y; Zhang X; Zhao Y; Zeng X; Zhang F; Zhang W
Arthritis Res Ther; 2018 Apr; 20(1):65. PubMed ID: 29636109
[TBL] [Abstract][Full Text] [Related]
13. Differences and similarities between IgG4-related disease with and without dacryoadenitis and sialoadenitis: clinical manifestations and treatment efficacy.
Wang M; Zhang P; Lin W; Fei Y; Chen H; Li J; Zhang L; Zheng W; Li Y; Zeng X; Zhou J; Lai Y; Liu X; Xue H; Cui Y; Zhou L; Zhao J; Zhang W
Arthritis Res Ther; 2019 Feb; 21(1):44. PubMed ID: 30709411
[TBL] [Abstract][Full Text] [Related]
14. B-cells depletion after treatment with rituximab predicts relapse of IgG4-related disease.
Lanzillotta M; Ramirez GA; Milani R; Dagna L; Della-Torre E
Rheumatology (Oxford); 2024 May; ():. PubMed ID: 38781535
[TBL] [Abstract][Full Text] [Related]
15. Treatment and outcomes in patients with IgG4-related disease using the IgG4 responder index.
Fernández-Codina A; Pinilla B; Pinal-Fernández I; López C; Fraile-Rodríguez G; Fonseca-Aizpuru E; Carballo I; Brito-Zerón P; Feijóo-Massó C; López-Dupla M; Cid MC; Martínez-Valle F; ; ;
Joint Bone Spine; 2018 Dec; 85(6):721-726. PubMed ID: 29452298
[TBL] [Abstract][Full Text] [Related]
16. Relapse patterns and predictors of IgG4-related diseases involved with autoimmune pancreatitis: A single-center retrospective study of 115 patients.
Miki M; Fujimori N; Oono T; Kawabe K; Ohno A; Matsumoto K; Teramatsu K; Tachibana Y; Ogawa Y
J Dig Dis; 2019 Mar; 20(3):152-158. PubMed ID: 30701685
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and therapeutic response of immunoglobulin G4-related disease: a retrospective study of 127 Chinese patients.
An W; Wu Z; Li M; Yu H; Zhao X; Wang X; Wang Y; Wang Q; Duan W; Kong Y; Ma H; Ou X; You H; Liu Y; Li P; Duan T; Jia J
Orphanet J Rare Dis; 2022 Aug; 17(1):307. PubMed ID: 35927746
[TBL] [Abstract][Full Text] [Related]
18. Prediction of new organ onset in recurrent immunoglobulin G4-related disease during 10 years of follow-up.
Liu Z; Peng Y; Li J; Lu H; Peng L; Zhou J; Zhou S; Huang C; Wang M; Zhu L; Chen H; Wang L; Fei Y; Zhao Y; Zeng X; Zhang W
J Intern Med; 2022 Jul; 292(1):91-102. PubMed ID: 35419810
[TBL] [Abstract][Full Text] [Related]
19. Different factors underlie recurrent and de novo organ involvement in immunoglobulin G4-related disease.
Mizushima I; Tsuge S; Fujisawa Y; Hara S; Suzuki F; Ito K; Fujii H; Yamada K; Kawano M
Rheumatology (Oxford); 2020 Mar; 59(3):513-518. PubMed ID: 31373632
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy of leflunomide and glucocorticoids for the maintenance of remission in patients with IgG4-related disease: a retrospective study and literature review.
Wang Y; Li K; Gao D; Luo G; Zhao Y; Wang X; Zhang J; Jin J; Zhao Z; Yang C; Zhu J; Zhang J; Huang F
Intern Med J; 2017 Jun; 47(6):680-689. PubMed ID: 28321964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
